FDA grants orphan-drug status to Aeterna's Neovastat for kidney cancer.
D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D009965:Orphan Drug Production; D014020:Tissue Extracts / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D014020:Tissue Extracts; C111481:shark cartilage extract